Cedar Mountain Advisors
RCUS icon

Cedar Mountain Advisors’s Arcus Biosciences RCUS Stock Holding History

Cedar Mountain Advisors’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$568 Hold
22
– – ﹤0.01% 997
2026
Q2 		$678 Hold
22
– – ﹤0.01% 1001
2026
Q1 		$475 Hold
22
– – ﹤0.01% 1021
2025
Q4 		$524 Hold
22
– – ﹤0.01% 598
2025
Q3 		$299 Buy
+22
New +$229 ﹤0.01% 635

Other funds holding RCUS

Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
Activest Wealth Management
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Cedar Mountain Advisors's RCUS Position: Q3 2026 in Review

Cedar Mountain Advisors held its Arcus Biosciences (RCUS) position steady in Q3 2026 at 22 shares worth $568. The position accounts for ﹤0.01% of the portfolio, ranked #997.

Cedar Mountain Advisors first reported a position in RCUS in Q3 2025 and has held it in 5 quarters since. The position peaked at $678 in Q2 2026. 18 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.

  • Cedar Mountain Advisors held 22 shares of Arcus Biosciences worth $568 as of Q3 2026.
  • Cedar Mountain Advisors left its Arcus Biosciences share count unchanged in Q3 2026.
  • Arcus Biosciences made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q3 2026, its #997 holding.
  • Cedar Mountain Advisors first reported a position in Arcus Biosciences in Q3 2025 and has held it in 5 quarters since.
  • Cedar Mountain Advisors's Arcus Biosciences position peaked at $678 in Q2 2026.
  • 18 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.

Based on Cedar Mountain Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.